» Authors » Olivier Potterat

Olivier Potterat

Explore the profile of Olivier Potterat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 759
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zurfluh L, Santos S, Ruppen A, Mosbacher J, Haslinger C, Ochsenbein-Kolble N, et al.
Biomed Pharmacother . 2025 Feb; 184:117919. PMID: 39983434
Preparations of Bryophyllum pinnatum have been used as a well-tolerated treatment of preterm labor, initially in anthroposophic hospitals and, more recently, also in conventional settings. In vitro studies with human...
2.
Potterat O, Kaufmann M, Tschopp C, Caj M, Reinhardt J, Prescimone A, et al.
Phytochemistry . 2024 Nov; 230:114329. PMID: 39549941
Twelve bufadienolides and six 19-norbufadienolides were isolated from the aerial parts of Helleborus foetidus. They consist of aglycons and glucosides and include nine previously undescribed compounds and a compound reported...
3.
Reinhardt J, Schertler L, Bussmann H, Sellner M, Smiesko M, Boonen G, et al.
Int J Mol Sci . 2024 Nov; 25(21). PMID: 39519010
Pre-clinical studies suggest that extracts prepared from the fruits of (VAC) interact with dopamine D2 receptors, leading to reduced prolactin secretion. In previous experiments, dopaminergic activity was mostly evaluated using...
4.
Zurfluh L, Duvaud L, Inci N, Potterat O, Simoes-Wust A, Mosbacher J
Planta Med . 2024 Apr; 90(10):757-765. PMID: 38599625
The medicinal plant was previously shown to block oxytocin (OT)-induced signals in myometrial cells, consistent with its tocolytic effect observed in patients. OT activates not only OT receptors but also...
5.
Areesanan A, Nicolay S, Keller M, Zimmermann-Klemd A, Potterat O, Grundemann C
Biomed Pharmacother . 2023 Nov; 168:115782. PMID: 37924786
Dry eye disease (DED) is a common chronic ocular surface disease. Available therapies are effective but often associated with side effects. This study investigates the potential of a Malva sylvestris...
6.
Schafer A, Rysz M, Schadeli J, Hubscher M, Khosravi H, Fehr M, et al.
Mol Pharmacol . 2023 Oct; 105(1):14-22. PMID: 37863663
The pregnane X receptor (PXR) is a ligand-activated regulator of cytochrome P450 (CYP)3A enzymes. Among the ligands of human PXR is hyperforin, a constituent of St John's wort (SJW) extracts...
7.
Chauveau A, Geirnaert A, Babst A, Treyer A, Lacroix C, Hamburger M, et al.
Biomed Pharmacother . 2023 Oct; 167:115615. PMID: 37778907
No abstract available.
8.
Chauveau A, Geirnaert A, Babst A, Treyer A, Lacroix C, Hamburger M, et al.
Biomed Pharmacother . 2023 Sep; 166:115420. PMID: 37673017
California poppy products are commonly used for the treatment of nervousness, anxiety and sleeping disorders. Pharmacologically relevant constituents include the main alkaloids californidine, escholtzine and protopine. However, only limited information...
9.
Heng M, Syafni N, Ramseyer J, Thuerig B, Tamm L, Hamburger M, et al.
J Agric Food Chem . 2023 Jul; 71(28):10590-10597. PMID: 37399340
Sumatra benzoin, a resin produced by and , is used as an aromatic agent and may have the potential to be developed as a new agricultural fungicide. In this context,...
10.
Winker M, Chauveau A, Smiesko M, Potterat O, Areesanan A, Zimmermann-Klemd A, et al.
Sci Rep . 2023 Jun; 13(1):9630. PMID: 37316493
Nonpsychotic mental diseases (NMDs) affect approximately 15% of pregnant women in the US. Herbal preparations are perceived a safe alternative to placenta-crossing antidepressants or benzodiazepines in the treatment of nonpsychotic...